19th International Conference of Drug Regulatory Authorities in New Delhi
The 19th International Conference of Drug Regulatory Authorities (ICDRA) workshop took place at the Yashobhoomi Convention Centre in Dwarka, New Delhi. The event, held from October 14 to 18, 2024, was hosted by the Central Drugs Standard Control Organization (CDSCO) and the Ministry of Health and Family Welfare, in collaboration with the World Health Organization (WHO). Union Minister of Health & Family Welfare, Jagat Prakash Nadda, inaugurated the conference.
Key Discussions and Objectives
The conference aimed to address quality issues, regulatory reforms, and the strengthening of regulatory systems. It focused on medical product safety, the detection and prevention of substandard products, and access to quality medical products. Discussions also covered the regulation of clinical trials, new technologies, and herbal medicines.
International Participation
Participants included regulatory authorities and health officials from WHO member states such as Singapore, Switzerland, South Africa, Brazil, and many others. Presentations were delivered on topics like access to medical products, quality of pharmaceutical materials, and regulation of advanced therapy medicinal products.
Outcomes and Recommendations
The workshop featured panel discussions and Q&A sessions, leading to the finalization of recommendations. The focus was on improving access to medical devices, reducing reliance on animal studies, and enhancing regulatory frameworks. The African Medicines Agency also shared updates on its operationalization.
Doubts Revealed
ICDRA -: ICDRA stands for the International Conference of Drug Regulatory Authorities. It’s a big meeting where people from different countries talk about how to make sure medicines are safe and work well.
New Delhi -: New Delhi is the capital city of India. It’s a big city where important meetings and events often take place.
Central Drugs Standard Control Organization -: The Central Drugs Standard Control Organization (CDSCO) is a part of the Indian government. It makes sure that medicines and medical devices in India are safe and effective.
Ministry of Health and Family Welfare -: The Ministry of Health and Family Welfare is a part of the Indian government. It works to keep people healthy and make sure they have access to good healthcare.
WHO -: WHO stands for the World Health Organization. It’s a global group that helps countries keep people healthy and fight diseases.
Regulatory reforms -: Regulatory reforms are changes in rules and laws to make sure medicines and medical devices are safe and effective. These changes help improve healthcare systems.
Medical product safety -: Medical product safety means making sure that medicines and medical devices do not harm people and work as they should.
Advanced therapy medicinal products -: Advanced therapy medicinal products are special types of medicines made using new technologies, like gene therapy. They can help treat diseases in new ways.
Reducing reliance on animal studies -: Reducing reliance on animal studies means finding new ways to test medicines without using animals. This is important for making testing more humane and efficient.
